Abiomed | search
Click here to view Abiomed news from 60+ newspapers.
Bookmark or Share- J&J to Buy Heart-Pump Maker Abiomed for $17.3 Billion - Bloomberg.comJohnson & Johnson, one of the world’s biggest makers of medical devices, said it will purchase Abiomed Inc. for about $17.3 billion, building on its portfolio of technology to assist heart ...
- Abiomed - WikipediaAbiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. [2] Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn ...
- Explore Impella® Technology - AbiomedThe Impella® Left Ventricular Support System. Advancing the Way Heart Disease is Treated. Learn more about how the FDA-approved Impella, the world's smallest heart pump, is safe, effective and supports your heart during a procedure. Hear the stories of patients and explore the latest innovations in Impella technology.
- Johnson & Johnson Completes Acquisition of AbiomedJohnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.
- Our Story | Abiomed.comAbiomed is founded to develop the first artificial heart. This interactive timeline shows how Abiomed’s mission evolved to focus on native heart recovery. Through its history, Abiomed has been dedicated to bringing the most advanced and innovative technology to patients and physicians.
More
